Efficacy and Safety of Dulaglutide Versus Insulin Glargine in Chinese T2DM Patients: A Subgroup Analysis of a Randomized Trial (AWARD-CHN2)

INTRODUCTION: To evaluate efficacy and safety data of dulaglutide in Chinese patients with type 2 diabetes mellitus (T2DM) who had inadequate glycemic control with 1–2 oral antihyperglycemic medications (OAMs). METHODS: This is a subgroup analysis of a phase 3, open-label, randomized, parallel-arm,...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yan, Li, Ling, De Peng, Yong, Song, Guang Yao, Ye, Shan Dong, Du, Li Ying, Hou, Jia Ning, Ji, Qiu He
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6612357/
https://www.ncbi.nlm.nih.gov/pubmed/31228090
http://dx.doi.org/10.1007/s13300-019-0646-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6612357/
https://www.ncbi.nlm.nih.gov/pubmed/31228090
http://dx.doi.org/10.1007/s13300-019-0646-y

Ejemplares similares